CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...
Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing faci...
Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, andArgonaut...
Bora Pharmaceuticals Co., Ltd. announced that it has successfully entered into an agreement for Emergent BioSolutions’ sterile man...
Partnership to accelerate development of lead product candidate, RO-104; a first-in-class tri-specific biologic for treating neovascular age-relat...
ChargePoint Technology, a powder and liquid transfer specialist, has announced the launch of a new robotic material handling solution aimed at increasing s...
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk...
Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth Des Plaines, IL, and Saa...
Syngene , a leading global contract research, development and manufacturing organization (CRDMO), announces the launch of its new protein production plat...
Cytiva is addressing industry challenges that hinder patient access and broader adoption of autologous CAR T cell therapies with the launch of the new Se...
Ribobay Pharma, a prominent Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO), in conjuncti...
New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...
Biopharmaceutical contract manufacturer SK pharmteco commits to production, testing, and release of Ferring’s U.S. approved ADSTILADRIN® ...
The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...
© 2025 Biopharma Boardroom. All Rights Reserved.
